InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.09
(
0.27%
)
US TECH 100
19,250.80
(
0.45%
)
Dow Jones
39,169.52
(
0.13%
)
Brent Oil
86.71
(
0.20%
)
Bitcoin
62,718.85
(
-0.21%
)
Post# of 252455
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

palindromy

Send PM Follow Ignore
Followers 4
Posts 712
Boards Moderated 0
Alias Born 12/16/2006

palindromy

Re: DewDiligence post# 63435

Friday, 06/13/2008 1:50:16 AM

Friday, June 13, 2008 1:50:16 AM

Post# of 252455
Dew, what do you think the path forward and timeline for IDX 899 is likely to be.
Assuming a partnership is done, would they commence a P3 for IDX 899 alone or immediately do a combination study. I haven't followed HIV drugs before, so would appreciate some info on the typical P3 duration and endpoints. Seems to me that not that many patients are required given the clear impact of the drug.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up